STELLIAM INVESTMENT MANAGEMENT, LP - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is and the CUSIP is 00163UAA4. A total of 27 filers reported holding AMAG PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
STELLIAM INVESTMENT MANAGEMENT, LP ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$16,265,000
-46.1%
11,500,000
-57.0%
0.54%
-46.5%
Q3 2016$30,177,000
+7.0%
26,750,000
+4.9%
1.01%
+3.5%
Q2 2016$28,209,000
+79.0%
25,500,000
+75.9%
0.98%
+100.0%
Q1 2016$15,760,00014,500,0000.49%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Birch Grove Capital LP 17,250,000$19,597,00018.38%
STEELHEAD PARTNERS LLC 17,000,000$19,264,0001.88%
Bruce & Co., Inc. 5,500,000$6,600,0001.78%
STELLIAM INVESTMENT MANAGEMENT, LP 26,750,000$30,177,0001.01%
Castle Creek Arbitrage, LLC 3,721,000$4,215,0000.43%
LINDEN ADVISORS LP 7,000,000$7,909,0000.36%
Sonora Investment Management, LLC 1,510,000$1,702,676,0000.36%
BASSO CAPITAL MANAGEMENT, L.P. 2,110,000$2,382,0000.35%
WOLVERINE ASSET MANAGEMENT LLC 18,400,000$20,808,0000.31%
SSI INVESTMENT MANAGEMENT LLC 1,975,000$2,221,0000.20%
View complete list of AMAG PHARMACEUTICALS INC shareholders